Search
Search the current U.S. Code within Title 21
Search by citation or keyword across the current edition within Title 21.
21 U.S.C. § 360bbb–3
Authorization for medical products for use in emergencies
Authorization for medical products for use in emergencies
21 U.S.C. § 355c
Research into pediatric uses for drugs and biological products
Research into pediatric uses for drugs and biological products
21 U.S.C. § 355–2
Actions for delays of generic drugs and biosimilar biological products
Actions for delays of generic drugs and biosimilar biological products
21 U.S.C. § 356–1
Accelerated approval of priority countermeasures
Accelerated approval of priority countermeasures
21 U.S.C. § 360aa
Recommendations for investigations of drugs for rare diseases or conditions
Recommendations for investigations of drugs for rare diseases or conditions
21 U.S.C. § 360bb
Designation of drugs for rare diseases or conditions
Designation of drugs for rare diseases or conditions
21 U.S.C. § 360bbb–3c
Expedited development and review of medical products for emergency uses
Expedited development and review of medical products for emergency uses
21 U.S.C. § 360bbb–4a
Priority review to encourage treatments for agents that present national security threats
Priority review to encourage treatments for agents that present national security threats
21 U.S.C. § 360cc
Protection for drugs for rare diseases or conditions
Protection for drugs for rare diseases or conditions
21 U.S.C. § 360ee
Grants and contracts for development of drugs for rare diseases and conditions
Grants and contracts for development of drugs for rare diseases and conditions
21 U.S.C. § 360ff
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for rare pediatric diseases